Skip to main content

Advertisement

Log in

Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Pulmonary toxicity and blood dyscrasias are rare side effects of sulfasalazine. Pulmonary pathology is variable, the most common being eosinophilic pneumonia with peripheral eosinophilia, and interstitial inflammation with or without fibrosis. We here present the case of a 68-year-old female patient treated for 6 months with sulfasalazine for rheumatoid arthritis. On laboratory examination, eosinophil count was 97×103 mm3. Thorocoscopic biopsy was performed . Histopathologic diagnosis was bronchiolitis obliterans organizing pneumonia (BOOP). This is the first case in the literature to present with sulfasalazine-induced BOOP in a patient with seronegative RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

BOOP:

Bronchiolitis obliterans organizing pneumonia

DMARS:

Disease-modifying antirheumatic drugs

RA:

Rheumatoid arthritis

References

  1. Luthra HS (2001) Extraarticularatoid rheumatoid arthritis. In: Kopman WJ (ed) Arthritis and allied conditions, 14th edn. Lippincott Williams & Wilkins, Philadelphia, pp1187–1201

  2. Lazarus S C (2000) Disorders of the intrathoracic airways. In: Murray M, Boushey N (eds) Respiratory medicine,3rd edn. WB Saunders, Philadelphia, pp 1361–1373

  3. Jackson CG, Clegg DO (2001) Sulfasalazine and minocycline. In: Kopman WJ (ed) Arthritis and allied conditions, 14th edn. Lippincott Williams & Wilkins, Philadelphia, pp 769–782

  4. Day RO (1998) Slow-acting antirheumatic drugs. In: Klippel JH, Dieppe AP (eds) Rheumatology, 2nd edn. London, Mosby, pp 2:3- 8.7–8.9

  5. Pary S D, Barbatzas C, Peel ET, Barton JR (2002) Sulphasalazine and lung toxicity. Eur Respir J 19:756–764

    Article  PubMed  Google Scholar 

  6. Mehandru S, Smith RL, Sidhu GS, Cassai N, Aranda CP (2002) Migratory pulmonary infiltrates in a patient with rheumatoid arthritis. Thorax 57:465–457

    Article  CAS  PubMed  Google Scholar 

  7. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suziki S (1992) Pulmonary infiltrates and skin pigmentation associated with sulfasalazine. Am J Gastroenterol 87:1654–1657

    CAS  PubMed  Google Scholar 

  8. Queyrel V, Catteau B, Michan- Pastuel, Fauchais AL, Delcy V, Lauray D (2001) DRESS (drug rush with eosinophilia and systemic symptoms) syndrome after sulfasalazine and carbamazepine: report of two cases. Rev Med Intern 22:582–586

    Article  CAS  Google Scholar 

  9. Mehandru S, Smith RL, Sidhu GS, Cassai N, Aranda CP (2002) Migratory pulmonary infiltrates in a patients with rheumatoid arthritis. Thorax 57:465–467

    Article  CAS  PubMed  Google Scholar 

  10. Wilson AW (2000) Pulmonary diseases of unknown origin and miscellaneous lung disorders. In:Armstrong P, Wilson AG, Dee P, Hansell DM (eds) Imaging of diseases of the chest, 3rd edn. London, Mosby, pp 637–688

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bahar Ulubaş.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulubaş, B., Şahin, G., Özer, C. et al. Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis. Clin Rheumatol 23, 249–251 (2004). https://doi.org/10.1007/s10067-003-0848-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-003-0848-5

Keywords

Navigation